Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol

NCT02905981 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Limited subjects, patient compliance

Conditions

Iron-Refractory Iron-Deficiency Anemia

Interventions

DRUG: Fer-In-Sol
DRUG: Shohl's solution
DRUG: Triferic

Sponsor

Rockwell Medical Technologies, Inc.